Connect with us

Press Release

Lab Grown Diamonds Shine Bright in Liberty, MO: Sustainable Luxury Without Compromise

Published

on

Lab Grown Diamonds, a pioneer in the field of sustainable luxury, is proud to announce its exquisite collection of diamond jewelry, including rings, earrings, pendants, and bracelets. Each piece in the collection is crafted using man-made diamonds, also known as lab-grown or created diamonds. This innovation ensures that customers can enjoy the beauty and elegance of diamonds without contributing to the environmental and ethical issues associated with traditional diamond mining.

Lab-grown diamonds are chemically, physically, and optically identical to mined diamonds, making them a perfect alternative for conscientious consumers. These diamonds are created in controlled laboratory environments, using advanced technological processes that replicate the conditions under which natural diamonds form in the Earth’s mantle. The result is a diamond that is indistinguishable from its mined counterpart, except for its origin. For more Information https://www.labgrown.com/

“Lab-grown diamonds offer a sustainable choice for those who love diamonds but are concerned about the environmental and human impact of mining,” says Mike Christensen, owner of Lab Grown Diamonds. “Our diamonds are as real as flowers grown in a greenhouse or ice made in a refrigerator. They provide the same sparkle, clarity, and beauty as mined diamonds but without the ethical concerns.”

The collection at Lab Grown Diamonds features a wide variety of jewelry pieces, designed to suit every taste and occasion. Highlights include:

Rings: From timeless solitaires to intricate halo settings, the ring collection showcases the versatility and brilliance of lab-grown diamonds. Each ring is a testament to the brand’s commitment to quality and sustainability.

Earrings: The earrings range features classic studs, elegant drop earrings, and modern designs, all set with dazzling lab-grown diamonds. These pieces are perfect for adding a touch of sparkle to any outfit.

Pendants: The pendants collection includes delicate solitaire pendants, intricate designs, and statement pieces, all showcasing the beauty of lab-grown diamonds. These pendants make a meaningful gift for any occasion.

Bracelets: From tennis bracelets to elegant bangles, the bracelet collection offers a variety of styles to suit every wrist. Each piece is designed to highlight the exceptional quality of lab-grown diamonds.

Lab Grown Diamonds is committed to providing customers with not only beautiful jewelry but also peace of mind. The company’s dedication to sustainability is reflected in every aspect of its business, from the sourcing of materials to the manufacturing process. By choosing lab-grown diamonds, customers can enjoy luxurious, high-quality jewelry while making a positive impact on the planet. For more Information https://www.labgrown.com/.

About

Lab Grown Diamonds, based in Liberty, MO, specializes in creating exquisite diamond jewelry using lab-grown diamonds. The company was founded on the principles of sustainability and ethical responsibility, offering customers a high-quality, eco-friendly alternative to traditional diamond jewelry. With a wide range of rings, earrings, pendants, and bracelets, Lab Grown Diamonds is dedicated to providing beautiful, timeless pieces that are kind to the Earth and its inhabitants.

For media inquiries, please contact:

Mike and Jeravae Christensen

1536 NE 96th St, Liberty, MO, 64068

Media Contact

Name
Lab Grown Diamonds
Contact name
Mike and Jeravae Christensen
City
Liberty
State
MO
Zip
64068
Country
US
Url
https://www.labgrown.com/

comtex tracking

COMTEX_453652900/2737/2024-06-11T06:33:48

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Medifakt Appoints Preethika Mandadi as Chief Executive Officer

Published

on

Medifakt, the health-to-earn DeSci ecosystem built on a cross-chain token economy, today announced the appointment of Preethika Mandadi as Chief Executive Officer. Preethika brings deep expertise in technology strategy, health innovation, and operations to the role, stepping in at a pivotal moment as Medifakt prepares for its global commercial launch.

About Preethika Mandadi

Preethika Mandadi is a technology strategist and health innovation leader who has driven Medifakt’s operations, product development, and go-to-market strategy. She holds a Master’s in Computer Information Technology from Purdue University, and brings enterprise experience from the State of Indiana and DXC Technology, where she led AI-driven analytics and business modernisation projects.

A certified Yoga Teacher (RYT 200), Preethika’s commitment to wellness is both professional and personal — the authentic foundation of the Medifakt mission. She is also the first author on a forthcoming peer-reviewed DeSci research paper on the Medifakt ecosystem, targeting a high-impact journal for December 2026 publication.

About Medifakt

Medifakt is a Decentralised Science (DeSci) health-to-earn ecosystem that rewards users for verified healthy behaviour through on-chain incentives. The company’s products include the FaktUp mobile application — a gamified mental wellness platform — alongside the Fakt-O-Band and Fakt-O-Ring BLE wearable devices that generate cryptographically signed, device-verified health data. Medifakt operates a dual-chain token economy: SOLFAKT on Solana serves as the earn-and-spend velocity token, while FAKT on Ethereum functions as the governance and store-of-value layer. Medifakt’s mission is to create a privacy-first, decentralised model for personal health data ownership — giving individuals full control over their wellness journey and rewarding them in real tradeable value.

Fore more information Visit: www.medifakt.com | email us at social@medifakt.com

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

AI & Blockchain Startup Edubuk Secures $50M Investment from Nimbus Capital

Published

on

New Delhi, India, March 24th, 2026, ZEX PR WIRE, Edubuk, a fast-scaling AI and blockchain startup, has secured a $50 million strategic investment commitment from Nimbus Capital, marking a major milestone in its mission to redefine global hiring infrastructure, powered by its upcoming $EBUK reward token launch.

Founded by Apoorva Bajaj (CFA, IIT Dhanbad; IIM Kozhikode Gold Medallist, with work-ex in Global Financial Markets with Goldman Sachs, DE Shaw, GlobalData) and Shivani Mehrotra (MBE from Lucknow University, Topper, UGC NET Qualified ex- Professor, Education leader, Microsoft Innovative Educator, Women in AI APAC finalist), Edubuk is tackling one of the world’s largest yet overlooked problems, fake credentials and broken verification systems, impacting over 500 million profiles globally, a $50billion+ issue.

  •  $50M strategic backing from Nimbus Capital
  • 100,000+ on-chain verifications
  •  Expanding across India, South East Asia, Middle East, Europe & Africa

At the core is TruCV, a blockchain-powered, tamper-proof CV platform integrated with DigiLocker, enabling instant credential verification, and TruJobs, an AI-driven job matching platform for employers.

Backed by global recognition and awards from G20, MIT, Harvard, GITEX, CNBC, CNN, Leap-to-Unicorn, STPI, and others, Edubuk is not just building a product; it is building the trust layer for the future of work.

This isn’t just a startup, it’s the infrastructure for a transparent, skill-first global workforce.

Website: https://www.edubuk.io/

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Steve Valdiserri Identifies Three Shifts Reshaping the Back End of Healthcare Finance

Published

on

  • Traverse City executive Steve Valdiserri outlines the operational trends he sees accelerating across revenue cycle management, AI adoption, and value-based care performance in 2026 and beyond.

Healthcare Finance Is Changing Faster Than Most Organizations Are Ready For

Michigan, USA, 24th March 2026, ZEX PR WIRE — The back end of healthcare finance has historically been defined by manual processes, siloed data systems, and reporting volumes that require significant staff time to produce and interpret. Steve Valdiserri, SVP of Operations at Tally and Accurio and Founding Partner of Avanti Strategy Group, has spent the past year working at the intersection of these systems and the AI tools designed to replace or augment them. He identifies three shifts that healthcare executives and operators should be tracking closely.

Shift One: AI Adoption Is Moving from Strategy to Operationalization

The question in healthcare AI has shifted. Organizations are no longer asking whether AI belongs in revenue cycle or financial reporting. They are asking how to operationalize it within existing workflows and regulatory constraints. Valdiserri sees this as meaningful progress, though he notes that the distance between adopting a tool and realizing its financial benefit remains significant for most organizations. The gap is typically operational, not technological.

At Tally, where he leads operations, the focus is on building the infrastructure that allows AI automation to produce consistent results for organizations managing insurance verification, claims submission, AR follow-up, and financial reporting. The tool is only as effective as the operational environment it runs in.

Shift Two: Attribution Is Becoming a Recognized Strategic Priority in Value-Based Care

For years in value-based care, attribution management was treated as a technical function handled by data teams with limited connection to executive strategy or operations. Valdiserri has argued consistently that this framing understates its importance. The patient panel determines the performance baseline for every value-based care program. If attribution is broken, the downstream investment in care management, quality programs, and payer engagement produces less return than it should.

He notes a growing recognition among VBC leaders that attribution deserves a dedicated operational strategy, including systematic payer engagement and ongoing panel validation. The organizations beginning to treat it that way are seeing earlier identification of performance gaps and more accurate financial projections from their risk-based contracts.

Shift Three: Healthcare Finance Metrics Are Being Simplified, Not Expanded

Counter to the general trend toward more reporting, Valdiserri sees leading healthcare finance teams moving toward fewer, higher-quality metrics. The volume of data available to healthcare organizations has grown faster than the capacity to interpret it strategically. His view, developed across a decade of VBC operations and now applied in revenue cycle contexts, is that most organizations need a small number of metrics that describe financial health clearly rather than a comprehensive dashboard that requires significant analysis time to interpret.

For revenue cycle, his working framework focuses on AR days, write-off rate, and gross charge distribution as core indicators. Other metrics matter, but these three describe the financial condition of the business in terms that allow for direct operational response.

What These Shifts Mean for Healthcare Operators

Each of these shifts rewards organizations that prioritize operational discipline over technology adoption speed. AI tools deliver better results in organizations that have already clarified their processes. Attribution strategy produces better financial outcomes when it is connected to executive decision-making rather than siloed in analytics. Simplified metrics work when an organization has already done the harder work of understanding which numbers actually drive performance.

Valdiserri’s current work across Tally, Accurio, and Avanti Strategy Group reflects a consistent thesis: the organizations that will benefit most from the changes underway in healthcare finance are the ones that invest first in the operational foundations that make those changes productive.

About Steve Valdiserri

Steve Valdiserri is a healthcare operations executive and entrepreneur based in Traverse City, Michigan. He serves as SVP of Operations at Tally and Accurio and as Founding Partner of Avanti Strategy Group. He previously held senior operational roles at VillageMD over approximately a decade. He completed a certificate in AI in Health Care from Harvard Medical School in October 2025 and holds a Bachelor of Arts in Economics from DePauw University. Connect with him at stevevaldiserri.com.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST